Member Exclusive

Synaptic pruning drugs could offer therapeutic strategies for autism and schizophrenia

Researchers at SUNY Downstate Medical Center (Brooklyn, NY, USA) have identified drugs that trigger synaptic pruning, which could be utilized in drug therapies for disorders with abnormal numbers of synapses, such as autism and schizophrenia.

Go to the profile of Peter Brown
Mar 02, 2017

Please sign in or register for FREE

Register to MedChemNet – the medicinal chemistry network

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.